Loading...

Abbott Laboratories (NYSE:ABT)

107.19 USD -1.89 USD ( -1.73% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

Wall Street
Price Targets

ABT Price Targets
Price Targets made by Wall Street

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

12-month price targets for ABT stock made by Wall Street professionals. The average price target is 142.08 USD with a low forecast of 112.11 USD and a high forecast of 166.43 USD.

Lowest
Price Target
112.11 USD
5% Upside
Average
Price Target
142.08 USD
33% Upside
Highest
Price Target
166.43 USD
55% Upside
Abbott Laboratories Competitors:
Price Targets
BFLY
Butterfly Network Inc
128% Upside
7775
Daiken Medical Co Ltd
84% Upside
VREX
Varex Imaging Corp
96% Upside
SONVF
Sonova Holding AG
17% Upside
ATRC
AtriCure Inc
97% Upside
7779
Cyberdyne Inc
122% Upside
ENOV
Enovis Corp
114% Upside
EW
Edwards Lifesciences Corp
32% Upside

Revenue
Forecast

ABT Revenue Forecast
Wall Street Forecast

Abbott Laboratories's Revenue forecast for three years ahead made by Wall Street analysts. Revenue is forecast to grow at a rate of 1% per year.

Year Avg Range
2024
By 17 analysts
44.3B USD
+7%
41.7B - 49.3B USD
2023
By 22 analysts
41.5B USD
-2%
38.9B - 46.1B USD
2022
By 23 analysts
42.2B USD
-2%
40B - 46B USD
CAGR:
Forecast
1%

Operating Income
Forecast

ABT Operating Income Forecast
Wall Street Forecast

Abbott Laboratories's Operating Income forecast for three years ahead made by Wall Street analysts. Operating Income is forecast to grow at a rate of 10% per year.

Year Avg Range
2024
By 16 analysts
11.4B USD
+11%
9.6B - 12.8B USD
2023
By 20 analysts
10.3B USD
+1%
8.4B - 11.7B USD
2022
By 20 analysts
10.2B USD
+19%
8B - 11.6B USD
CAGR:
Forecast
10%

Net Income
Forecast

ABT Net Income Forecast
Wall Street Forecast

Abbott Laboratories's Net Income forecast for three years ahead made by Wall Street analysts. Net Income is forecast to grow at a rate of 11% per year.

Year Avg Range
2024
By 17 analysts
9.6B USD
+12%
8.7B - 10.6B USD
2023
By 23 analysts
8.6B USD
0%
7.7B - 9.5B USD
2022
By 24 analysts
8.6B USD
+22%
8.1B - 9.6B USD
CAGR:
Forecast
11%

See Also

Other Stocks